118 - Developing Novel Methods and Biomarkers to Detect Growth Hormone Doping - Martin Bidlingmaier, MD

01/16/24 • 54 min

Dr. Martin Bidlingmaier is Head of the Endocrine Laboratory, and he leads the Neuroendocrine Research Group in the Department of Internal Medicine at the Ludwig-Maximilians-University of Munich. Martin conducts clinical and basic research, particularly focusing on the development and validation of laboratory methods to diagnose and monitor pituitary and adrenal hormones, physiology, pathophysiology and biomarkers of growth hormone action, and endocrine aspects of doping in sports. In this episode, we discuss his work identifying new biomarkers and developing novel methods to measure growth hormone and detect growth hormone doping. He describes how growth hormone isoforms and the formation of complexes can help distinguish doping, and how the protein soluble α-klotho has emerged as a potential biomarker that may be useful in anti-doping analyses.

Previous Episode

117 - Keeping Sport Clean in New Zealand and Beyond - Nick Paterson

Nick Paterson is Chief Executive of Drug Free Sport New Zealand, which will soon become part of a new Integrity Sport and Recreation Commission in New Zealand. He is also Governing Board Chair for the Institute of Anti-Doping Organisations (iNADO). In this episode, Nick talks more about Drug Free Sport New Zealand, including the organization’s history, the resources and services they provide, and their role in the global anti-doping community. He also discusses upcoming changes for sport integrity in New Zealand, and their key focus areas for the future.

Next Episode

119 - How Tasso is Innovating Blood Collection in Anti-Doping and Beyond - RJ Asplund and Erwin Berthier, PhD

Collecting blood samples is critical in anti-doping testing and a variety of clinical applications such as diagnostics and disease monitoring. However, traditional blood testing approaches can be a major pain point for athletes, sport organizations, patients, and their care teams. Tasso, Inc. is a company developing innovative products to improve the user experience surrounding blood collection. In this episode, Dr. Erwin Berthier and RJ Asplund describe Tasso's current devices and how they work, the benefits of these products, and how their work is helping advance anti-doping. Erwin is Co-Founder and Chief Technology Officer and RJ is Vice President of Commercial at Tasso, Inc.